首页> 外文期刊>FEMS Yeast Research >Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm.
【24h】

Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm.

机译:氨溴索影响伏立康唑对假丝酵母生物膜的抵抗力。

获取原文
获取原文并翻译 | 示例
           

摘要

The ability to form biofilm on different surfaces is typical of most Candida species. Microscopic structure and genetic aspects of fungal biofilms have been the object of many studies because of very high resistance to antimycotic agents because of the scarce permeability of the external matrix and to the alterations in cell metabolism. In our study, 31 isolates of Candida parapsilosis, isolated from bloodstream infections, were tested for their ability to produce biofilm and were found to be good producers. The susceptibility to voriconazole, assayed by colorimetrical XTT assay, revealed a very elevated minimum inhibitory concentrations for sessile cells in comparison with planktonic ones. The addition of ambroxol, a mucolytic agent, increased the susceptibility of biofilm forming cells to voriconazole. Expression of the efflux pump genes CDR and MDR was analyzed in biofilms alone or treated with ambroxol, evidencing a role of ambroxol in the expression of genes involved in azole resistance mechanisms of C.[NON-BREAKING SPACE]parapsilosis biofilms. In conclusion, our data seem to encourage the use of different substances in combination with classical antimycotics, with the aim of finding a solution to the increasing problem of the resistance of biofilms formed on medical devices by nonalbicans Candida species. Copyright 2012 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.
机译:大多数假丝酵母菌都具有在不同表面形成生物膜的能力。真菌生物膜的微观结构和遗传方面已成为许多研究的目标,因为由于外部基质的稀疏通透性以及对细胞代谢的改变,它们对抗真菌剂的抗药性很高。在我们的研究中,从血液感染中分离出31株假丝酵母念珠菌,检测它们产生生物膜的能力,发现它们是良好的生产者。通过比色XTT测定法对伏立康唑的敏感性表明,与浮游细胞相比,无柄细胞的最低抑菌浓度大大提高。氨溴索(一种粘液溶解剂)的添加增加了生物膜形成细胞对伏立康唑的敏感性。在单独的生物膜中或用氨溴索处理的生物膜中分析了外排泵基因CDR和MDR的表达,证明了氨溴索在参与C. [NON-BREAKING SPACE] parapsilosis生物膜的唑耐药机制的基因表达中的作用。总之,我们的数据似乎鼓励将不同的物质与经典的抗真菌药结合使用,目的是寻找解决方案,以解决日益增长的非白色念珠菌物种在医疗器械上形成的生物膜抗性问题。版权所有2012欧洲微生物学会联合会。由布莱克韦尔出版有限公司出版。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号